Alkermes plc (ALKS)
NASDAQ · Healthcare
Alkermes plc Income Statement 2010–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 1.48B | 1.56B | 1.66B | 1.11B | 1.17B | 1.04B | 1.17B | 1.09B | 903.4M | 745.7M | 628.3M | 618.8M | 596.3M | 575.5M | 390.0M | 186.6M | 178.3M |
| Gross Profit | 1.28B | 1.31B | 1.41B | 893.7M | 976.4M | 860.4M | 990.6M | 917.9M | 748.6M | 613.6M | 489.3M | 443.0M | — | 405.1M | 262.4M | 134.5M | 128.8M |
| Profitability | |||||||||||||||||
| Operating Income | 254.0M | 420.6M | 414.1M | -6.1M | 97.7M | -112.4M | -175.5M | -99.1M | -147.9M | -208.7M | -224.3M | -87.1M | 34.5M | 81.8M | -88.3M | -45.6M | -43.0M |
| EBITDA | 281.1M | 449.2M | 489.0M | 71.8M | 176.4M | -30.6M | -95.1M | 4.5M | -49.4M | -114.4M | -138.7M | 10.9M | — | 155.6M | -40.4M | -37.0M | -18.0M |
| Net Income | 241.7M | 367.1M | 355.8M | -158.3M | -48.2M | -110.9M | -196.6M | -139.3M | -157.9M | -208.4M | -227.2M | -30.1M | — | 25.0M | -113.7M | -45.5M | -39.6M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 169M | 169M | 170M | 164M | 165M | 159M | 158M | 156M | 154M | 152M | 149M | 145M | 144M | 137M | 115M | 96M | 95M |
Alkermes plc Income Statement — FAQ
Alkermes plc (ALKS) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALKS's income statement history?
The chart and table above show Alkermes plc's income statement by year and by quarter, including the growth rate.